Search results
Results from the WOW.Com Content Network
Samuel Rahbar (Persian: سموئیلِ رهبر Samu'il-e Rahbar May 12, 1929 - November 10, 2012) was an Iranian scientist who discovered [1] the linkage between diabetes and HbA1C, a form of hemoglobin used primarily to identify plasma glucose concentration over time. Rahbar was born into a Jewish family in the Iranian city of Hamedan in 1929.
There are several ways to measure glycated hemoglobin, of which HbA1c (or simply A1c) is a standard single test. [5] HbA1c is measured primarily to determine the three-month average blood sugar level and is used as a standard diagnostic test for evaluating the risk of complications of diabetes and as an assessment of glycemic control .
The terms type 1 and 2 were for some time forgotten. In 1976, they were revived and popularized by Andrew Cudworth after he discovered the link between type 1 diabetes and a specific genetic marker. [64] [68]
It was first discovered in 1990 or 1991. ... is similar in all regions of the world. ... , but the results were unclear for effects on HbA1c, body ...
If you recently received a prediabetes diagnosis, you’re far from alone. According to the National Institutes of Health, more than 1 in 3 U.S. adults are living with prediabetes.The good news?
Opioids are among the world's oldest known drugs. [13] [14] Use of the opium poppy for medical, recreational, and religious purposes can be traced to the 4th century BCE, when Hippocrates wrote about it for its analgesic properties, stating, "Divinum opus est sedare dolores." ("Divine work is the easing of pain") [15]
This page was last edited on 7 September 2009, at 11:39 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; additional terms may apply.
Furthermore, a recent study showed that patients described as being "Uncontrolled Diabetics" (defined in this study by HbA1C levels >8%) showed a statistically significant decrease in the HbA1C levels after a 90-day period of seven-point self-monitoring of blood glucose (SMBG) with a relative risk reduction (RRR) of 0.18% (95% CI, 0.86–2.64% ...